Organ damage in high-risk patients with systemic and incomplete lupus syndromes

Rheumatology International

Volumn 33, Issue 10, 2013, Pages 2585-2590

  Olsen, Nancy J ^a   Yousif, Maha ^b   Mutwally, Azza ^b   Cory, Melinda ^b   Elmagboul, Nada ^a   Karp, David R ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoantibodies; Damage; Ethnicity; Incomplete lupus; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AFRICAN AMERICAN; ARTHRITIS; ARTICLE; AVASCULAR NECROSIS; BLOOD VESSEL INJURY; BREAST CANCER; CARDIOVASCULAR DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ACTIVITY SCORE; DISEASE COURSE; DISEASE DURATION; ENDOMETRIUM CANCER; EYE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HIGH RISK PATIENT; HIGH RISK POPULATION; HISPANIC; HUMAN; INCOMPLETE LUPUS ERYTHEMATOSUS; INFLAMMATION; KIDNEY CARCINOMA; KIDNEY INJURY; LUNG DISEASE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PERIPHERAL VASCULAR DISEASE; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84885389128     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2783-3     Document Type: Article

References (23)

1. Vilá LM, Alarcón GS, McGwin G, Friedman AW, Baethge BA, Bastian HM, Fessler BJ, Reveille JD, Group LS (2004) Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) 43:358-363
2. Korbet SM, Schwartz MM, Evans J, Lewis EJ, Group CS (2007) Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 18:244-254
3. Tan E, Cohen A, Fries J, Masi A, McShane D, Rothfield N, Schaller J, Talal N, Winchester R (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
4. Ståhl Hallengren C, Nived O, Sturfelt G (2004) Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus 13:85-88
5. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-369
6. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived O, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G (1997) The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 40:809-813
7. Dixon WG, Carmona L, Finckh A, Hetland ML, Kvien TK, Landewe R, Listing J, Nicola PJ, Tarp U, Zink A, Askling J (2010) EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis 69:1596-1602
8. Wandstrat A, Carr-Johnson F, Branch V, Gray H, Fairhurst A, Reimold A, Karp D, Wakeland E, Olsen N (2006) Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 27:153-160
9. Vilá LM, Alarcón GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD, Group LS (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150-2155
10. Kamen DL, Barron M, Parker TM, Shaftman SR, Bruner GR, Aberle T, James JA, Scofield RH, Harley JB, Gilkeson GS (2008) Autoantibody prevalence and lupus characteristics in a unique African American population. Arthritis Rheum 58:1237-1247
11. Sung YK, Hur NW, Sinskey JL, Park D, Bae SC (2007) Assessment of damage in Korean patients with systemic lupus erythematosus. J Rheumatol 34:987-991
12. Alarcón GS, McGwin G, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP, Group PS (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95-101
13. Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801-1808
14. Laustrup H, Voss A, Green A, Junker P (2010) SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. Lupus 19:239-246
15. Grönhagen CM, Fored CM, Granath F, Nyberg F (2011) Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1,088 patients in Sweden. Br J Dermatol 164:1335-1341
16. Laustrup H, Voss A, Green A, Junker P (2009) Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol 38:128-132
17. Chambers SA, Allen E, Rahman A, Isenberg D (2009) Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) 48:673-675
18. Mok CC, Ho CT, Wong RW, Lau CS (2003) Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 30:1513-1519
19. Rabbani MA, Habib HB, Islam M, Ahmad B, Shah SM, Tahir S, Merchant D, Ahmad A (2010) Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan. Lupus 19:1573-1578
20. Danila MI, Pons-Estel GJ, Zhang J, Vilá LM, Reveille JD, Alarcón GS (2009) Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford) 48:542-545
21. Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, Kroemer G (2003) Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22:3927-3936
22. Lightstone L (2013) Minimising steroids in lupus nephritis - will B cell depletion pave the way? Lupus 22:390-399
23. Petri M, Purvey S, Fang H, Magder LS (2012) Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort. Arthritis Rheum 64:4021-4028